StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Gilead Sciences, Inc.
NasdaqGS:GILD
Sector
Location
Market Cap
USD 139.01 B
Share Price
USD 111.75
Avg Daily Volume
9,624,542
Change (1 day)
0.21%
Change (1 year)
67.82%
Change (YTD)
20.98%
Gilead Sciences, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2025: USD 28.73 B
Gilead Sciences, Inc. Revenue is USD 28.73 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 4.68% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
-
Gilead Sciences, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 27.45 B, a 1.50% change year over year.
-
Gilead Sciences, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 27.04 B, a -1.56% change year over year.
-
Gilead Sciences, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 27.47 B, a 7.46% change year over year.
-
Gilead Sciences, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 25.56 B, a 12.54% change year over year.
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
CSL Limited
USD 158.90
CSL.AX
+0.55
0.35%
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
MERCK Kommanditgesellschaft auf Aktien
USD 130.94
MRK.DE
+0.74
0.57%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.43
600276.SS
+0.11
1.54%
Takeda Pharmaceutical Company Limited
USD 30.72
4502.T
+0.21
0.69%
Alnylam Pharmaceuticals, Inc.
USD 331.91
ALNY
+2.14
0.65%
Key Data
| Date | Revenue | Revenue | Gross Profit | Operating Income |
|---|
Competitors
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Chugai Pharmaceutical Co., Ltd.
USD 49.30
4519.T
+0.76
1.57%
CSL Limited
USD 158.90
CSL.AX
+0.55
0.35%
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Regeneron Pharmaceuticals, Inc.
USD 547.36
REGN
-0.38
-0.07%
MERCK Kommanditgesellschaft auf Aktien
USD 130.94
MRK.DE
+0.74
0.57%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.43
600276.SS
+0.11
1.54%
Takeda Pharmaceutical Company Limited
USD 30.72
4502.T
+0.21
0.69%
Alnylam Pharmaceuticals, Inc.
USD 331.91
ALNY
+2.14
0.65%